移植后1年移植物状态与eGFR复合终点改进器官共享联合网络五级评级系统
该研究利用2008至2018年器官共享联合网络数据,将移植后1年移植物失败或eGFR<30 ml/min/1.73 m²的复合终点与传统终点进行对比,发现复合终点能更好地区分移植中心基于长期死亡供者移植物存活的评级,且由复合终点衍生的第3至5级中心5年平均eGFR显著高于第1级中心。
要点
- 复合终点为移植后1年移植物失败或eGFR<30 ml/min/1.73 m²。
- 复合终点较传统终点能更好地区分移植中心长期死亡供者移植物存活。
- 由复合终点衍生的5级系统中,第3至5级中心5年平均eGFR显著高于第1级中心。
主要发现
- 复合终点为移植后1年移植物失败或eGFR<30 ml/min/1.73 m²,较传统终点在基于长期死亡供者移植物存活对移植中心分层方面表现更好。
- 传统终点下第1至5级5年条件移植物存活分别为72.9%、74.8%、75.4%、77.0%和79.7%,复合终点下分别为71.1%、74.4%、76.9%、77.0%和78.4%。
- 由复合终点衍生的五级系统中,第3、4、5级中心5年平均eGFR显著高于第1级中心。
- 仅由传统终点衍生的各层级间5年eGFR无显著差异。
局限性
- 原文称该研究为概念验证研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Performance of kidney transplant programs in the United States is monitored and publicly reported by the Scientific Registry of Transplant Recipients (SRTR). With relatively few allograft failure events per program and increasing homogeneity in program performance, quantifying meaningful differences in program competency based only on 1-year survival rates is challenging. METHODS: We explored whether the traditional end point of allograft failure at 1 year can be improved by incorporating a measure of allograft function (i.e., eGFR) into a composite end point. We divided SRTR data from 2008 through 2018 into a training and validation set and recreated SRTR tiers, using the traditional and composite end points. The conditional 5-year deceased donor allograft survival and 5-year eGFR were then assessed using each approach. RESULTS: Compared with the traditional end point, the composite end point of graft failure or eGFR <30 ml/min per 1.73 m2 at 1-year post-transplant performed better in stratifying transplant programs based on long-term deceased donor graft survival. For tiers 1 through 5 respectively, the 5-year conditional graft survival was 72.9%, 74.8%, 75.4%, 77.0%, and 79.7% using the traditional end point and 71.1%, 74.4%, 76.9%, 77.0%, and 78.4% with the composite end point. Additionally, with the five-tier system derived from the composite end point, programs in tier 3, tier 4, and tier 5 had significantly higher mean eGFRs at 5 years compared with programs in tier 1. There were no significant eGFR differences among tiers derived from the traditional end point alone. CONCLUSIONS: This proof-of-concept study suggests that a composite end point incorporating allograft function may improve the post-transplant component of the five-tier system by better differentiating between transplant programs with respect to long-term graft outcomes.
引用
- Wang K, Deng Y, Stewart D, et al. A Composite End Point of Graft Status and eGFR at 1 Year to Improve the Scientific Registry of Transplant Recipients' Five-Tier Rating System. J Am Soc Nephrol. 2022. PMID: 35537779. doi:10.1681/ASN.2022010078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。